Skip to content

US · TTRX

Turn Therapeutics Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Westlake Village, CA 91362

Price · as of 2026-09-04

$9.80

Market cap 280.9M

Price history

Weekly OHLC price history for TTRX, USD per share
WeekOpenHighLowCloseVolume
Oct 6, 2025 – Oct 10, 2025$10.00$26.50$6.23$7.450
Oct 13, 2025 – Oct 17, 2025$7.19$7.19$4.81$5.060
Oct 20, 2025 – Oct 24, 2025$5.01$5.36$4.07$5.080
Oct 27, 2025 – Oct 31, 2025$5.18$5.58$4.78$4.850
Nov 3, 2025 – Nov 7, 2025$4.78$4.84$3.83$4.020
Nov 10, 2025 – Nov 14, 2025$3.96$4.40$3.65$4.000
Nov 17, 2025 – Nov 21, 2025$3.98$3.98$2.57$3.270
Nov 24, 2025 – Nov 28, 2025$3.24$3.56$3.05$3.520
Dec 1, 2025 – Dec 5, 2025$3.50$4.40$3.44$4.310
Dec 8, 2025 – Dec 12, 2025$4.37$4.37$2.94$3.410
Dec 15, 2025 – Dec 19, 2025$3.40$3.40$2.92$3.000
Dec 22, 2025 – Dec 26, 2025$3.00$3.12$2.70$2.740
Dec 29, 2025 – Jan 2, 2026$2.80$4.79$2.80$4.690
Jan 5, 2026 – Jan 9, 2026$4.77$5.22$4.33$4.620
Jan 12, 2026 – Jan 16, 2026$4.58$5.51$4.14$4.560
Jan 19, 2026 – Jan 23, 2026$4.56$5.00$4.39$4.860
Jan 26, 2026 – Jan 30, 2026$4.82$5.02$3.96$4.120
Feb 2, 2026 – Feb 6, 2026$4.05$4.30$3.55$3.850
Feb 9, 2026 – Feb 13, 2026$3.99$3.99$3.51$3.510
Feb 16, 2026 – Feb 20, 2026$3.53$3.63$3.20$3.490
Feb 23, 2026 – Feb 27, 2026$3.49$4.01$3.33$3.600
Mar 2, 2026 – Mar 6, 2026$3.60$3.84$3.33$3.500
Mar 9, 2026 – Mar 13, 2026$3.44$3.83$3.33$3.610
Mar 16, 2026 – Mar 20, 2026$3.68$3.71$3.24$3.440
Mar 23, 2026 – Mar 27, 2026$3.43$3.63$3.20$3.460
Mar 30, 2026 – Apr 2, 2026$3.33$3.38$3.01$3.350
Apr 6, 2026 – Apr 10, 2026$3.58$3.58$3.09$3.350
Apr 13, 2026 – Apr 17, 2026$3.39$3.61$3.14$3.460
Apr 20, 2026 – Apr 24, 2026$3.42$3.55$3.20$3.550
Apr 27, 2026 – May 1, 2026$3.50$3.80$3.40$3.800
May 4, 2026 – May 8, 2026$3.80$3.90$3.66$3.790
May 11, 2026 – May 15, 2026$3.70$4.10$3.70$4.050
May 18, 2026 – May 22, 2026$4.16$5.25$4.10$5.130
May 25, 2026 – May 29, 2026$5.17$5.48$4.57$5.200
Jun 1, 2026 – Jun 5, 2026$5.68$6.75$5.10$5.280
Jun 8, 2026 – Jun 12, 2026$5.37$6.19$4.83$6.050
Jun 15, 2026 – Jun 18, 2026$6.18$6.60$5.79$5.870
Jun 22, 2026 – Jun 26, 2026$5.75$6.98$5.55$6.930
Jun 29, 2026 – Jul 2, 2026$6.94$7.39$6.51$7.120
Jul 6, 2026 – Jul 10, 2026$7.18$11.69$7.10$9.440
Jul 13, 2026 – Jul 17, 2026$9.47$10.18$8.51$9.120
Jul 20, 2026 – Jul 24, 2026$9.34$10.48$8.50$8.540
Jul 27, 2026 – Jul 31, 2026$8.59$8.63$7.17$8.360
Aug 3, 2026 – Aug 7, 2026$8.51$10.59$8.43$10.410
Aug 10, 2026 – Aug 14, 2026$10.50$10.95$9.49$9.570
Aug 17, 2026 – Aug 21, 2026$9.83$10.18$9.35$9.460
Aug 24, 2026 – Aug 28, 2026$9.39$10.28$9.04$9.840
Aug 31, 2026 – Sep 4, 2026$9.83$10.50$9.00$9.800

Valuation

MetricValueUpside
IC Value
P/E-15.53
P/B10.59
P/S
EV/EBITDA-14.20
PEG-20.19
P/TBV13.18

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for TTRX, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025$3.61

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Turn Therapeutics Inc.

        Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

        CEO
        Bradley E. Burnam
        Employees
        2
        Beta
        2.10

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for TTRX: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        TTRXTurn Therapeutics Inc.$10.41280.9M-15.5310.59-14.20-20.1913.180.00%0.00%0.00%-141.67%946.44%-44.95%0.020.870.851.5976.92%85.92%-5.47%-0.43438.74%0.00%0.00%8.55%-7.62-16.43-0.26
        AGENAgenus Inc.$7.78323.98M$6.06-22%-0.40-0.340.816.82-0.3129.63%-18.00%0.10%77.75%19.47%-102.53%-1.24-0.370.410.015.34-99.97%10.37%0.00%-172.38%-0.49150.50%0.00%0.00%0.09%-20.63-2.673.71-14.17
        ANIXAnixa Biosciences, Inc.$3.41116.02M-9.957.24-8.627.240.00%0.00%0.00%-62.73%-4708.65%-58.55%0.018.087.710.09-12.82%-2.21%-6.54%-3.65-2886.52%0.00%0.00%0.00%-8.10-13.217.63
        CGTXCognition Therapeutics, I…$1.0694.87M-3.252.23-1.732.230.00%0.00%0.00%-88.60%1301.36%-59.75%0.02-3676.853.453.361.56-62.35%-13.66%-32.18%-1.77669.43%0.00%0.00%15.68%-0.84-1.64-4.92
        GLSIGreenwich LifeSciences, I…$14.39211.22M-18.701024.66-18.38-102.831024.660.00%0.00%0.00%-1340.94%526.85%-376.92%0.001.061.060.3218.18%36.43%-2.74%-1.70268.56%0.00%0.00%0.58%-18.29-35.897.22
        HURATuHURA Biosciences, Inc.$2.09133.1M-3.034.35-3.008.930.00%0.00%0.00%-169.18%-315.57%-127.02%0.03-50.850.780.610.10-48.09%87.37%-30.42%-4.67-274.97%0.01%0.00%0.01%-2.77-3.18-2.61
        IKTInhibikase Therapeutics, …$2.40316.88M-4.071.14-0.341.140.00%0.00%0.00%-36.05%1233.51%-34.49%0.0021.7021.542.61-57.76%45.18%-14.14%-3.35659.77%0.00%0.00%42.13%-0.34-0.6413.30
        IRDOpus Genetics, Inc.$3.78312.1M$15.26+304%-63.11203.92220.47-64.17203.92100.00%-271.90%-349.33%-449.36%144.72%-113.86%0.00-26.336.436.200.94-62.79%29.15%37.84%-1.13%-4.53132.18%0.00%0.00%0.48%-79.92-87.50217.2947.32
        SEERSeer, Inc.$2.19120.41M$11.52+426%-1.410.406.450.810.4049.67%-483.85%-456.60%-25.08%-72.83%-22.21%0.0912.8412.230.33-7.91%15.57%-6.94%-44.47%-2.83-43.18%0.00%0.00%18.31%0.751.26-3.61-0.57
        TVGNTevogen Bio Holdings Inc.$6.8528.52M-0.68-2.17-0.80-0.94-2.170.00%0.00%0.00%352.48%486.03%-669.89%-0.38-133.630.220.10-0.1072.65%3.29%-69.39%-1.74230.42%0.00%0.00%0.00%-0.78-1.65-64.96
        VTGNVistaGen Therapeutics, In…$0.3012.19M$18.27+6,052%-0.300.5816.200.33-3.080.58100.00%-5683.69%-5491.33%-131.59%827.99%-104.86%0.033.673.550.429.58%161.11%57.46%-323.87%-5.19764.40%0.00%0.00%0.00%0.330.36-18.75-16.85

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $9.80) − 1 = — (IC, example).